Compare ARMOUR Residential REIT, Inc. (ARR) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARMOUR Residential REIT, Inc. vs Eli Lilly And Co — how do they compare? ARMOUR Residential REIT, Inc. trades at $16.7 (market cap $2.07B), while Eli Lilly And Co trades at $1,213.07 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 521.7× ARMOUR Residential REIT, Inc.'s market cap, and ARMOUR Residential REIT, Inc. pays the higher dividend (17.28%). Which is the better fit depends on your goals.
| ARR | LLY | |
|---|---|---|
Market Cap | $2.07B | $1.08T |
Sector | Financials | Health |
52-Week High | $19.12 | $1.24K |
52-Week Low | $14.05 | $639.43 |
Dividend Yield | 17.28% | 0.57% |
Enterprise Value | — | $1.13T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARMOUR Residential REIT, Inc.
ARMOUR Residential REIT Inc is a real estate investment trust that invests in residential mortgage-backed securities or RMBS. These are issued or guaranteed by U.S.-government-sponsored enterprises, such as Fannie Mae, Freddie Mac, or Ginnie Mae. The company's investment portfolio is composed of mortgage-backed securities, adjustable-rate mortgage securities, and multifamily mortgage-backed securities. In terms of total fair value, most Armour's investments are long-term, fixed-rate agency RMBS. Multifamily RMBS also represents a substantial amount. Fannie Mae guarantees most of the company's holdings. Armour derives substantially all its revenue as interest income from its investments.
Read more on ARR →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
